Sildenafil use in congenital diaphragmatic hernia

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 94, Issue 6, 2009, Pages

  Hunter, Lindsey ^a   Richens, T ^a   Davis, C ^a   Walker, G ^a   Simpson, J H ^a  

^a ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE; SILDENAFIL;

CONGENITAL DIAPHRAGM HERNIA; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG EXPOSURE; DRUG SAFETY; HUMAN; LETTER; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; PULMONARY HYPERTENSION;

HERNIA, DIAPHRAGMATIC; HUMANS; HYPERTENSION, PULMONARY; INFANT, NEWBORN; NITRIC OXIDE; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; PURINES; RESPIRATION, ARTIFICIAL; RETROSPECTIVE STUDIES; SCOTLAND; SULFONES; TREATMENT OUTCOME;

EID: 70350462564     PISSN: 13592998     EISSN: 14682052     Source Type: Journal    
DOI: 10.1136/adc.2008.153684     Document Type: Letter

References (2)

1. Noori S, Friedlich P, Wong P, et al. Cardiovascular effects of sildenafil in neonates and infants with congenital diaphragmatic hernia and pulmonary hypertension. Neonatology 2007;91:92-100. (Pubitemid 46272384)
2. Carroll WD, Dhillon R. Sildenafil as a treatment for pulmonary hypertension. Arch Dis Child 2003;88: 827-828